26
Views
2
CrossRef citations to date
0
Altmetric
Review

New developments in antibradycardic devices

, , &
Pages 321-333 | Published online: 09 Jan 2014

References

  • Markewitz A. Annual report 2004 of the German cardiac pacemaker registry. Herzschrittmacherther Elektrophysiol.17(3), 146–173 (2006).
  • Barold S, Zipes D. Cardiac pacemakers and antiarhythmic devices. In: Heart Disease. A textbook of Cardivascular Medicine. Braunwald E (Ed.). WB Saunders, NY, USA, 705–741 (1997).
  • Gras D, Mabo P, Tang T et al. Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync Study. Pacing Clin. Electrophysiol.21, 2249–2255 (1998).
  • Penicka M, Bartunek J, De Bruyne B et al. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography. Circulation109, 978–983 (2004).
  • Nelson GS, Berger RD, Fetics BJ et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation102, 3053–3059 (2000).
  • Cleland JG, Daubert JC, Erdmann E et al; CARE-HF Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. Med.352(15), 1539–1549 (2005).
  • Abraham WT, Fisher WG, Smith AL et al. Cardiac resynchronization in chronic heart failure. N. Engl. J. Med.346, 1845–1853 (2002).
  • Funck RC, Blanc JJ, Mueller HH, Schade-Brittinger C, Bailleul C, Maisch B; BioPace Study Group. Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the ‘Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)’ study. Europace8, 629–635 (2006).
  • Pollak WM, Simmons JD, Interian A Jr, Castellanos A, Myerburg R, Mitriani RD. Pacemaker diagnostics: a critical appraisal of current technology. Pacing Clin. Electrophysiol.26, 76–98 (2003).
  • Padeletti L, Michelucci A, Fröhlig G, Corbucci G, van Oort G, Barold SS. Digital technology in cardiac pacing: methods for morphology analysis of sensed endocavitary signals. J. Interv. Card. Electrophysiol.14(1), 9–16 (2005).
  • Simantirakis EN, Vardas PE. Cardiac pacing in sleep apnoea: diagnostic and therapeutic implications. Europace8, 984–987 (2006).
  • Fantoni C, Raffa S, Regoli F et al. Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. J. Am. Coll. Cardiol.46(10), 1875–1882 (2005).
  • Kaye G, Arthur W, Edgar D, Lippert M, Czygan G. The use of unipolar intracardiac impedance for discrimination of haemodynamically stable and unstable arrhythmias in man. Europace8, 988–993 (2006).
  • Dohrmann ML, Goldschlager NF. Myocardial stimulation threshold in patients with cardiac pacemakers: effect of physiologic variables, pharmacologic agents and lead electrodes. Cardiol. Clin.3(4), 527–537 (1985).
  • Clarke M, Liu B, Schuller H et al. Automatic adjustment of pacemaker stimulation output correlated with continuously monitored capture thresholds: a multicenter study. European Microny Study Group. Pacing Clin. Electrophysiol.21(8), 1567–1575 (1998).
  • Luria D, Gurevitz O, Bar-Lev D et al. Use of automatic threshold tracking function with non-low polarization leads: risk for algorithm malfunction. Pacing Clin. Electrophysiol.27(4), 453–459 (2004).
  • Berg M, Frohlig G, Schwerdt H, Becker R, Schieffer H. Reliability of an automatic sensing algorithm. Pacing Clin. Electrophysiol.15(11 Pt 2), 1880–1885 (1992).
  • Brugada P. What evidence do we have to replace in-hospital implantable cardioverter defibrillator follow-up? Clin. Res. Cardiol.95(Suppl. 3), III3–III9 (2006).
  • Theuns DA, Res JC, Jordaens LJ. Home monitoring in ICD therapy: future perspectives. Europace5(2), 139–142 (2003).
  • Toselli T, Regoli F, Pratola C et al. Implantable cardioverter-defibrillator home monitoring technology. Ital. Heart J.5(Suppl. 1), 30S–31S (2006).
  • Lamaison D, Motreff P, Jean F et al. [The place of telemedicine in rhythmology and cardiac pacing]. Arch. Mal. Coeur Vaiss.97(11), 1160–1164 (2004).
  • Wallbruck K, Stellbrink C, Santini M, Gill J, Hartmann A, Wunderlich E. The value of permanent follow-up of implantable pacemakers – first results of a European trial. Biomed. Tech. (Berl.)47(Suppl. 1 Pt 2), 950–953 (2002).
  • Fauchier L, Sadoul N, Kouakam C et al. Potential cost savings by telemedicine-assisted long-term care of implantable cardioverter defibrillator recipients. Pacing Clin. Electrophysiol.28(Suppl. 1), S255–S259 (2005).
  • Ellery S, Pakrashi T, Paul V, Sack S on behalf of the Home CARE Phase 0 Study Investigators. Predicting mortality and rehospitalization in heart failure patients with Home Monitoring – The Home CARE pilot study. Clin. Res. Cardiol.95(Suppl. 3), iii29–iii35 (2006).
  • van Oosterhout MF, Prinzen FW, Arts T et al. Asynchronous electrical activation induces asymmetrical hypertrophy of the left ventricular wall. Circulation98(6), 588–595 (1998).
  • Karpawich PP, Rabah R, Haas JE. Altered cardiac histology following apical right ventricular pacing in patients with congenital atrioventricular block. Pacing Clin. Electrophysiol.22(9), 1372–1377 (1999).
  • Saxon LA, Stevenson WG, Middlekauff HR, Stevenson LW. Increased risk of progressive hemodynamic deterioration in advanced heart failure patients requiring permanent pacemakers. Am. Heart J.125(5 Pt 1), 1306–1310 (1993).
  • Sweeney MO, Hellkamp AS, Ellenbogen KA et al; Mode Selection Trial Investigators. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation107(23), 2932–2937 (2003).
  • Wilkoff BL, Cook JR, Epstein AE et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual chamber And VVI Implantable Defibrillator (DAVID) Trial. JAMA288(24), 3115–3123 (2002).
  • Mattioli AV, Vivoli D, Mattioli G. Influence of pacing modalities on the incidence of atrial fibrillation in patients without prior atrial fibrillation. A prospective study. Eur. Heart J.19(2), 282–286 (1998).
  • Mattioli AV, Castellani ET, Vivoli D, Sgura FA, Mattioli G. Prevalence of atrial fibrillation and stroke in paced patients without prior atrial fibrillation: a prospective study. Clin. Cardiol.21(2), 117–122 (1998).
  • Connolly SJ, Kerr CR, Gent M et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N. Engl. J. Med.342(19), 1385–1391 (2000).
  • Lamas GA, Lee KL, Sweeney MO et al. Mode selection trial in sinus-node dysfunction. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N. Engl. J. Med.346(24), 1854–1862 (2002).
  • Cleland JG, Coletta AP, Nikitin N, Louis A, Clark A. Update of clinical trials from the American College of Cardiology 2003. EPHESUS, SPORTIF-III, ASCOT, COMPANION, UK-PACE and T-wave alternans. Eur. J. Heart Fail.5(3), 391–398 (2003).
  • Nielsen JC, Kristensen L, Andersen HR, Mortensen PT, Pedersen OL, Pedersen AK. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. J. Am. Coll. Cardiol.42(4), 614–623 (2003).
  • Kristensen L, Nielsen JC, Mortensen PT, Pedersen OL, Pedersen AK, Andersen HR. Incidence of atrial fibrillation and thromboembolism in a randomised trial of atrial versus dual chamber pacing in 177 patients with sick sinus syndrome. Heart90(6), 661–666 (2004).
  • Lamas GA, Orav EJ, Stambler BS et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N. Engl. J. Med.338(16), 1097–1104 (1998).
  • Himmrich E, Kramer LI, Fischer W, Dorr T, Reinecke H. [Support of spontaneous atrioventricular conduction in patients with DDR(R) pacemakers: effectiveness and safety]. Herz26(1), 69–74 (2001).
  • Stierle U, Kruger D, Vincent AM et al. An optimized AV delay algorithm for patients with intermittent atrioventricular conduction. Pacing Clin. Electrophysiol.21(5), 1035–1043 (1998).
  • Nielsen JC, Pedersen AK, Mortensen PT, Andersen HR. Programming a fixed long atrioventricular delay is not effective in preventing ventricular pacing in patients with sick sinus syndrome. Europace1(2), 113–120 (1999).
  • Savoure A, Frohlig G, Galley D et al. A new dual-chamber pacing mode to minimize ventricular pacing. Pacing Clin. Electrophysiol.28(Suppl. 1), S43–S46 (2005).
  • Sweeney MO, Shea JB, Fox V et al. Randomized pilot study of a new atrial-based minimal ventricular pacing mode in dual-chamber implantable cardioverter-defibrillators. Heart Rhythm1(2), 160–167 (2004).
  • Frohlig G. [The role of cardiac pacing in atrial arrhythmia prevention]. Z. Kardiol.94(Suppl. 4), IV/53–IV/59 (2005).
  • Ogawa M, Suyama K, Kurita T et al. Acute effects of different atrial pacing sites in patients with atrial fibrillation: comparison of single site and biatrial pacing. Pacing Clin. Electrophysiol.24(10), 1470–1478 (2001).
  • Papageorgiou P, Anselme F, Kirchhof CJ et al. Coronary sinus pacing prevents induction of atrial fibrillation. Circulation96(6), 1893–1898 (1997).
  • Ricci R, Santini M, Puglisi A et al. Impact of consistent atrial pacing algorithm on premature atrial complex number and paroxysmal atrial fibrillation recurrences in brady-tachy syndrome: a randomized prospective cross over study. J. Interv. Card. Electrophysiol.5(1), 33–44 (2001).
  • Wiberg S, Lonnerholm S, Jensen SM, Blomstrom P, Ringqvist I, Blomstrom-Lundqvist C. Effect of right atrial overdrive pacing in the prevention of symptomatic paroxysmal atrial fibrillation: a multicenter randomized study, the PAF-PACE study. Pacing Clin. Electrophysiol.26(9), 1841–1848 (2003).
  • Hoffmann E, Sulke N, Edvardsson N et al; Atrial Fibrillation Therapy Trial Investigators. New insights into the initiation of atrial fibrillation: a detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features. Circulation113(16), 1933–1941 (2006).
  • Coumel P, Friocourt P, Mugica J, Attuel P, Leclercq JF. Long-term prevention of vagal atrial arrhythmias by atrial pacing at 90/minute: experience with 6 cases. Pacing Clin. Electrophysiol.6(3 Pt 1), 552–560 (1983).
  • Sra J, Biehl M, Blanck Z et al. Spontaneous reinitiation of atrial fibrillation following transvenous atrial defibrillation. Pacing Clin. Electrophysiol.21(5), 1105–1110 (1998).
  • Tse HF, Lau CP, Ayers GM. Atrial pacing for suppression of early reinitiation of atrial fibrillation after successful internal cardioversion. Eur. Heart J.21(14), 1167–1176 (2000).
  • Tse HF, Lau CP, Ayers GM. Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol. Heart82(3), 319–324 (1999).
  • Israel CW, Gronefeld G, Ehrlich JR, Li YG, Hohnloser SH. Prevention of immediate reinitiation of atrial tachyarrhythmias by high-rate overdrive pacing: results from a prospective randomized trial. J. Cardiovasc. Electrophysiol.14(9), 954–959 (2003).
  • Lee MA, Weachter R, Pollak S et al. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J. Am. Coll. Cardiol.41(11), 1926–1932 (2003).
  • Padeletti L, Purerfellner H, Adler SW et al. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J. Cardiovasc. Electrophysiol.14(11), 1189–1195 (2003).
  • Lewalter T, Yang A, Pfeiffer D et al. Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: results from the VIP registry. Pacing Clin. Electrophysiol.29(2), 124–134 (2006).
  • Schuchert A, Bub E, Braun M et al. Reduktion des AF-burden bei Schrittmacherpatienten mit paroxysmalem Vorhofflimmern mit getriggerter gegenüber getriggerter plus kontinuierlicher Vorhofstimulation. Z. Kardiol.93(Suppl. 3), 15–4 (2004).
  • Yang A, Hochhäusler M, Saborowski F et al. Einfluss der induktionsmechanismen von paroxysmalem Vorhofflimmern auf die Dauer der Arrhythmieepisoden bei Patienten mit implantiertem Zweikammerschrittmacher. Z. Kardiol.93(Suppl. 3), 15–4 (2004) (Abstract).
  • Bernstein AD, Daubert JC, Fletcher RD. The revised NASPE/BPEG generic code for antibradycardia, adaptive rate, and multisite pacing. North American Society of Pacing and Electrophysiology/Britisch Pacing and Electrophysiology Group. Pacing Clin. Electrophysiol.25, 260–264 (2002) (Abstract).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.